Literature DB >> 3508243

Cerebral aminoacids in portal-systemic encephalopathy: lack of evidence for altered gamma-aminobutyric acid (GABA) function.

R F Butterworth1, J F Giguère.   

Abstract

Construction of an end-to-side portocaval anastomosis in the rat resulted, 4 weeks later, in sustained hyperammonemia and two- to threefold increases in brain ammonia. Measurement of cerebral amino acids using a sensitive double-isotope dansyl microtechnique revealed substantial increases in the glutamine content of cerebral cortex and brain stem. Glutamate levels were found to be concomitantly reduced in both brain regions compared to those of sham-operated controls. The gamma-aminobutyric acid (GABA) content of cerebral cortex and brain stem was unaffected by portocaval shunting, as were activities of the GABA nerve-terminal marker enzyme glutamic acid decarboxylase (GAD). These findings suggest that impaired GABA function may not play a major role in the pathogenesis of hepatic encephalopathy associated with portocaval shunts. Preliminary evidence suggests that decreased cerebral glutamate may reflect its loss from the releasable (neurotransmitter) pool.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3508243     DOI: 10.1007/bf01001783

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  20 in total

1.  Experimental hepatic encephalopathy. Changes of the level of wakefulness in the rat with portacaval shunt.

Authors:  C Beaubernard; F Salomon; D Grange; M J Thangapregassam; J Bisbuth
Journal:  Biomedicine       Date:  1977-06

2.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

3.  The effect of porta-caval anastomosis upon the energy state and upon acid-base parameters of the rat brain.

Authors:  T Holmin; B K Siesjö
Journal:  J Neurochem       Date:  1974-03       Impact factor: 5.372

4.  Hepatic encephalopathy and GABA.

Authors:  W A Raabe
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

5.  Behavioral model of early hepatic encephalopathy in rats.

Authors:  J D Warbritton; M A Geyer; B W Jeppsson; J E Fischer
Journal:  Surg Forum       Date:  1979

6.  Regulation of glutaminase by exogenous glutamate, ammonia and 2-oxoglutarate in synaptosomal enriched preparation from rat brain.

Authors:  E Kvamme; K Lenda
Journal:  Neurochem Res       Date:  1982-06       Impact factor: 3.996

7.  Portacaval anastomosis: brain and plasma metabolite abnormalities and the effect of nutritional therapy.

Authors:  A M Mans; J F Biebuyck; D W Davis; R A Hawkins
Journal:  J Neurochem       Date:  1984-09       Impact factor: 5.372

8.  Hepatic encephalopathy and the gamma-aminobutyric-acid neurotransmitter system.

Authors:  D F Schafer; E A Jones
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

Review 9.  Ammonia: key factor in the pathogenesis of hepatic encephalopathy.

Authors:  R F Butterworth; J F Giguère; J Michaud; J Lavoie; G P Layrargues
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr

10.  Effects of ammonium chloride on synaptic transmission in the rat hippocampal slice.

Authors:  Y Théorĕt; M F Davies; B Esplin; R Capek
Journal:  Neuroscience       Date:  1985-03       Impact factor: 3.590

View more
  13 in total

Review 1.  Pathogenesis and treatment of portal-systemic encephalopathy: an update.

Authors:  R F Butterworth
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

Review 2.  Glutamatergic synaptic dysfunction in hyperammonemic syndromes.

Authors:  V L Rao; C R Murthy; R F Butterworth
Journal:  Metab Brain Dis       Date:  1992-03       Impact factor: 3.584

3.  Cerebrospinal fluid amino acids in relation to neurological status in experimental portal-systemic encephalopathy.

Authors:  G Therrien; R F Butterworth
Journal:  Metab Brain Dis       Date:  1991-06       Impact factor: 3.584

Review 4.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

5.  Activities of neuronal and astrocytic marker enzymes in autopsied brain tissue from patients with hepatic encephalopathy.

Authors:  J Lavoie; J F Giguère; G P Layrargues; R F Butterworth
Journal:  Metab Brain Dis       Date:  1987-12       Impact factor: 3.584

6.  Changes in glutamate-cycle enzyme mRNA levels in a rat model of hepatic encephalopathy.

Authors:  J W Thomas; C Banner; J Whitman; K D Mullen; E Freese
Journal:  Metab Brain Dis       Date:  1988-06       Impact factor: 3.584

7.  Cerebral amino acid changes in an animal model of intrauterine growth retardation.

Authors:  C Chanez; O Rabin; M Heroux; J F Giguere
Journal:  Metab Brain Dis       Date:  1993-03       Impact factor: 3.584

8.  Regional amino acid neurotransmitter changes in brains of spf/Y mice with congenital ornithine transcarbamylase deficiency.

Authors:  L Ratnakumari; I A Qureshi; R F Butterworth
Journal:  Metab Brain Dis       Date:  1994-03       Impact factor: 3.584

9.  Hepatic encephalopathy influences high-affinity uptake of transmitter glutamate and aspartate into the hippocampal formation.

Authors:  W Schmidt; G Wolf; K Grüngreiff; M Meier; T Reum
Journal:  Metab Brain Dis       Date:  1990-03       Impact factor: 3.584

10.  Aspartate aminotransferase, malate dehydrogenase, and pyruvate carboxylase activities in rat cerebral synaptic and nonsynaptic mitochondria: effects of in vitro treatment with ammonia, hyperammonemia and hepatic encephalopathy.

Authors:  L Faff-Michalak; J Albrecht
Journal:  Metab Brain Dis       Date:  1991-12       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.